CID 16095342

Gsk269962a

Structural Information

Molecular Formula
C29H30N8O5
SMILES
CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6
InChI
InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)
InChIKey
YOVNFNXUCOWYSG-UHFFFAOYSA-N
Compound name
N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

30
References

1201
Patents

570.2339 Da
Monoisotopic Mass

2.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 571.24118 233.6
[M+Na]+ 593.22312 247.2
[M+NH4]+ 588.26772 236.0
[M+K]+ 609.19706 246.0
[M-H]- 569.22662 242.5
[M+Na-2H]- 591.20857 240.3
[M]+ 570.23335 237.8
[M]- 570.23445 237.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe